Find clinical trials for Glioblastoma (GBM) in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Glioblastoma (GBM) trials near Philadelphia, PA, USA:
efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 20 other locations
Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM)....
Phase 2
Philadelphia, Pennsylvania, United States
This research study is for Glioblastoma (GBM) patients who will be beginning Optune as part of their clinical care, which is a nove...
Philadelphia, Pennsylvania, United States and 1 other location
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
Philadelphia, Pennsylvania, United States and 61 other locations
therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after sur...
Phase 2, Phase 3
Pennington, New Jersey, United States and 7 other locations
INCMGA00012, and stereotactic radiosurgery (SRS) for recurrent Glioblastoma (GBM). The investigators hypothesize that the proposed ...
Phase 2
Philadelphia, Pennsylvania, United States
The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM...
Phase 2
Philadelphia, Pennsylvania, United States and 22 other locations
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...
Philadelphia, Pennsylvania, United States and 132 other locations
receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma (GBM) expr...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 24 other locations
to as "CART-EGFR-IL13Ra2 cells") in patients with EGFR-amplified glioblastoma, IDH-wildtype that has recurred following prior radiotherapy....
Phase 1
Philadelphia, Pennsylvania, United States
Clinical trials
Research sites
Resources
Legal